QUIDEL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-09-01: Reporting owner Stenzel Timothy Todd; Form 4; Security Non-Qualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-12: Reporting owner SCHULER JACK W; Form 4; Security Non-Qualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-12: Reporting owner PULIDO MARK; Form 4; Security Non-Qualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-12: Reporting owner POLAN MARY LAKE PH D; Form 4; Security Non-Qualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-09-01 | Stenzel Timothy Todd Officer (Chief Science Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,977 21,977 owned after | $15.75 exercise price | 2009-09-23 | |
| 2009-05-12 | SCHULER JACK W Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,002 16,002 owned after | $11.96 exercise price | 2009-05-14 | |
| 2009-05-12 | PULIDO MARK Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,003 21,003 owned after | $11.96 exercise price | 2009-05-14 | |
| 2009-05-12 | POLAN MARY LAKE PH D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,002 16,002 owned after | $11.96 exercise price | 2009-05-14 | |
| 2009-05-12 | DAMMEYER RODNEY F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,002 16,002 owned after | $11.96 exercise price | 2009-05-14 | |
| 2009-05-12 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,002 16,002 owned after | $11.96 exercise price | 2009-05-14 | |
| 2009-05-12 | Brown Thomas D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,002 16,002 owned after | $11.96 exercise price | 2009-05-14 | |
| 2009-04-10 | McLeod Scot M Officer (Sr. VP - Operations) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,509 50,509 owned after | $8.50 exercise price | 2009-04-14 | |
| 2009-04-10 | RADAK JOHN MATTHEW Officer (Chief Financial Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,640 75,640 owned after | $8.50 exercise price | 2009-04-14 | |
| 2009-04-10 | Bujarski Robert Joseph Officer (Sr. VP, General Counsel & Secy) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,287 56,287 owned after | $8.50 exercise price | 2009-04-14 | |
| 2009-04-10 | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +68,534 68,534 owned after | $8.50 exercise price | 2009-04-14 | |
| 2009-04-10 | BRYANT DOUGLAS C Director, Officer (President/CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +205,212 205,212 owned after | $8.50 exercise price | 2009-04-14 | |
| 2009-02-02 | BRYANT DOUGLAS C Director, Officer (President/CEO-Elect) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +700,000 700,000 owned after | $12.36 exercise price | 2009-02-04 |